These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27562545)
1. Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study. Solberg DK; Bentsen H; Refsum H; Andreassen OA BMC Psychiatry; 2016 Aug; 16(1):299. PubMed ID: 27562545 [TBL] [Abstract][Full Text] [Related]
2. Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia. Solberg DK; Bentsen H; Refsum H; Andreassen OA Acta Psychiatr Scand; 2015 Oct; 132(4):293-300. PubMed ID: 25597473 [TBL] [Abstract][Full Text] [Related]
3. Smoking and Serum Lipid Profiles in Schizophrenia. An HM; Tan YL; Tan SP; Shi J; Wang ZR; Yang FD; Huang XF; Soars JC; Kosten TR; Zhang XY Neurosci Bull; 2016 Aug; 32(4):383-8. PubMed ID: 27017941 [TBL] [Abstract][Full Text] [Related]
4. Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan. Chung KH; Tsai SY; Lee HC Psychiatry Clin Neurosci; 2007 Aug; 61(4):428-33. PubMed ID: 17610669 [TBL] [Abstract][Full Text] [Related]
5. A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia. Solberg DK; Refsum H; Andreassen OA; Bentsen H Acta Neuropsychiatr; 2019 Aug; 31(4):202-212. PubMed ID: 31178002 [TBL] [Abstract][Full Text] [Related]
6. Suicidal behavior in schizophrenia may be related to low lipid levels. Ainiyet B; Rybakowski JK Med Sci Monit; 2014 Aug; 20():1486-90. PubMed ID: 25141886 [TBL] [Abstract][Full Text] [Related]
7. Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations. Tessier C; Sweers K; Frajerman A; Bergaoui H; Ferreri F; Delva C; Lapidus N; Lamaziere A; Roiser JP; De Hert M; Nuss P Transl Psychiatry; 2016 Oct; 6(10):e906. PubMed ID: 27701405 [TBL] [Abstract][Full Text] [Related]
8. Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia. Suzuki T; Uchida H; Sakurai H; Ishizuki T; Tsunoda K; Takeuchi H; Mimura M Psychiatry Res; 2015 Jun; 227(2-3):265-9. PubMed ID: 25882098 [TBL] [Abstract][Full Text] [Related]
9. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS. Samara MT; Engel RR; Millier A; Kandenwein J; Toumi M; Leucht S Eur Neuropsychopharmacol; 2014 Nov; 24(11):1767-72. PubMed ID: 25219937 [TBL] [Abstract][Full Text] [Related]
10. Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters. Skibinska M; Kapelski P; Pawlak J; Rajewska-Rager A; Dmitrzak-Weglarz M; Szczepankiewicz A; Czerski P; Twarowska-Hauser J Psychiatry Res; 2017 Oct; 256():396-402. PubMed ID: 28689143 [TBL] [Abstract][Full Text] [Related]
11. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study. Dursun SM; Szemis A; Andrews H; Reveley MA J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536 [TBL] [Abstract][Full Text] [Related]
12. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy. Horwitt MK; Harvey CC; Dahm CH Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436 [TBL] [Abstract][Full Text] [Related]
13. Is the assessment of lipid profile performed up to seventy two hours from hospital admission due to acute coronary syndrome still valid? Konopka A; Chodkowska E; Piotrowski W; Stepińska J Kardiol Pol; 2004 Sep; 61(9):243-50; discussion 251-2. PubMed ID: 15531936 [TBL] [Abstract][Full Text] [Related]
14. Serum lipid concentration with reference to the clinical and immunological status of HIV infected men. Christeff N; Lortholary O; Casassus P; Thobie N; Dalle MT; Veyssier P; Guillevin L; Nunez EA Ann Med Interne (Paris); 1995; 146(7):490-5. PubMed ID: 8787290 [TBL] [Abstract][Full Text] [Related]
15. One-year functional outcomes of naturalistically treated patients with schizophrenia. Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065 [TBL] [Abstract][Full Text] [Related]
16. Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan. Huang TL; Chen JF Schizophr Res; 2005 Dec; 80(1):55-9. PubMed ID: 15964176 [TBL] [Abstract][Full Text] [Related]
17. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Svensson M; Schmidt EB; Jørgensen KA; Christensen JH Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564 [TBL] [Abstract][Full Text] [Related]
19. [Study on the dynamic variations and influencing factors of serum lipid levels during pregnancy and postpartum]. Xu D; Liang C; Chen L; Wu XD; He J Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):227-233. PubMed ID: 29747266 [No Abstract] [Full Text] [Related]
20. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study. Peña J; Segarra R; Ojeda N; García J; Eguiluz JI; Gutiérrez M J Psychiatr Res; 2012 Jun; 46(6):774-81. PubMed ID: 22487311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]